In the media September 27, 2023
NoCamels, a publication of Israeli innovation and technology, highlighted the expansion of Deep TMS Treatment...
In the media August 26, 2023
South Florida Hospital News & Healthcare Report profiles the first adoption of BrainsWay Deep TMS...
In the media August 8, 2023
BrainsWay Chief Medical Officer, Dr. Aron Tendler, describes to HIT Consultant the landscape of modern...
In the media August 3, 2023
A Fox affiliate in Duluth, MN introduces viewers to Deep TMS, through an interview with Dr. Eric Johnson...
In the media July 24, 2023
A study, “Deep transcranial magnetic stimulation alters resting-state neurophysiological traits in...
In the media July 21, 2023
The unique business model of Novus Neurology is detailed by Healio, wherein Deep TMS technicians are...
In the media July 14, 2023
BrainsWay Chief Executive Officer, Hadar Levy, is interviewed by Authority Magazine about his philosophy...
In the media July 9, 2023
While medication and psychotherapy have repeatedly been shown to reduce symptoms of depression, they...
In the media June 21, 2023
Leah Scanlan, Director at Aspen Counseling, a division of Rosecrance, and Rosecrance alum Jonna A....
In the media June 22, 2023
Major depressive disorder (‘MDD’ or depression) is the leading cause of disability globally, affecting...
In the media June 9, 2023
The treatment that helped [Galit] Blecher is called repetitive transcranial magnetic stimulation (TMS)...
In the media June 8, 2023
“The ultimate goal of the endocrine glands is to maintain a balanced state of ‘homeostasis,’”...
In the media May 23, 2023
For patients with treatment-resistant major depressive disorder, deep transcranial magnetic stimulation...
In the media May 16, 2023
BrainsWay announced that it launched an investigator-initiated study (IIS) program for its Deep TMS technology....
In the media May 1, 2023
The defining qualities of rTMS treatment make it a potential first-line treatment when pharmacotherapy...
In the media April 28, 2023
The most significant advantage of TMS therapy for OCD patients is the reduction in symptoms. Patients...
In the media April 11, 2023
Obsessive-compulsive disorder (OCD) is a chronic and debilitating condition that impacts over 2% of the...
In the media April 10, 2023
Novus piloted a new model over two years ago in which they partner with primary care practices to address...
